40 Cases In Aredia, Zometa MDL Survive Dismissal Bid
A federal judge has denied a bid by Novartis Pharmaceuticals Corp. to toss 40 cases in multidistrict litigation that alleges the company failed to adequately warn that its bone cancer drugs...To view the full article, register now.
Already a subscriber? Click here to view full article